Gapping up
In reaction to strong earnings/guidance: LITB +8.9%, SGYP +7.4%, DL +5.2%, LZB +4.3%, LOW +3.9%, PETM +3.6%, JACK +3.5%, MNK +3.5%, SPLS +2.7%, TGT +2.6%, MTSI +1.4%
Select Brazil related names showing strength: ABGB +5.9%, EBR +4.4%, ABEV +3.1%, GOL +3.1%, CPL +2.5%, BBD +2%, VIV +1.7%, GGB +1.5%, TSU +1.5%, .
Other news: AGIO +9.8% (announced early Phase 1 data showing clinical acivity of AG-120 as a single agent in advanced acute myeloid leukemia), OMER +6.5% (announced positive data using OMS721), NBG +4.9% (cont move higher following strong Greece mkts overnight), PERY +4.3% (CalSTRS, Legion Partners call on PERY board to form an independent committee to evaluate strategic alternatives), SUNE +3.7% (cont strength pre-mkt after yday's 29% move), ENPH +2.8% (Co and SolarWorld enter global strategic partnership), CEL +2.5% (still checking, but announced that a purported class action was filed against the co and another cellular operator ), VA +2.5% (cont momentum post IPO), AMRN +2.3% (light volume), PLKI +1.6% (Red Mountain Capital disclosed a 5.1% stake in a 13-D Filing; Continue to engage in dialogue with mgmt), LNBB +1.4% (seeing reports that co is working with Sandler O'Neil to explore a sale), CRAY +1.1% (announced that Cloudera Enterprise is now pre-integrated into Cray's new big data analytics appliance)
Analyst comments: JAH +4.4% (initiated with a Buy at BTIG Research), ASML +2.3% (upgraded to Buy from Hold at Evercore ISI), POT +1.8% (upgraded to Outperform from Mkt Perform at Raymond James), MOS +1.6% (upgraded to Positive from Neutral at Susquehanna)
In reaction to strong earnings/guidance: LITB +8.9%, SGYP +7.4%, DL +5.2%, LZB +4.3%, LOW +3.9%, PETM +3.6%, JACK +3.5%, MNK +3.5%, SPLS +2.7%, TGT +2.6%, MTSI +1.4%
Select Brazil related names showing strength: ABGB +5.9%, EBR +4.4%, ABEV +3.1%, GOL +3.1%, CPL +2.5%, BBD +2%, VIV +1.7%, GGB +1.5%, TSU +1.5%, .
Other news: AGIO +9.8% (announced early Phase 1 data showing clinical acivity of AG-120 as a single agent in advanced acute myeloid leukemia), OMER +6.5% (announced positive data using OMS721), NBG +4.9% (cont move higher following strong Greece mkts overnight), PERY +4.3% (CalSTRS, Legion Partners call on PERY board to form an independent committee to evaluate strategic alternatives), SUNE +3.7% (cont strength pre-mkt after yday's 29% move), ENPH +2.8% (Co and SolarWorld enter global strategic partnership), CEL +2.5% (still checking, but announced that a purported class action was filed against the co and another cellular operator ), VA +2.5% (cont momentum post IPO), AMRN +2.3% (light volume), PLKI +1.6% (Red Mountain Capital disclosed a 5.1% stake in a 13-D Filing; Continue to engage in dialogue with mgmt), LNBB +1.4% (seeing reports that co is working with Sandler O'Neil to explore a sale), CRAY +1.1% (announced that Cloudera Enterprise is now pre-integrated into Cray's new big data analytics appliance)
Analyst comments: JAH +4.4% (initiated with a Buy at BTIG Research), ASML +2.3% (upgraded to Buy from Hold at Evercore ISI), POT +1.8% (upgraded to Outperform from Mkt Perform at Raymond James), MOS +1.6% (upgraded to Positive from Neutral at Susquehanna)